ARCHIVES

Von Eschenbach To Leave FDA Jan. 20, Says He Was “In Love” With The Agency.

This article is from The Cancer Letter archive.

Vol. 34 No. 46 | December 19, 2008

Download PDF Visit The Full Archive

Related Articles

New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial

September 24, 2010

NCAB Removes Its Restrictions On PDQ Access, Permits NCI Staff To Decide

February 7, 1986

Amgen Commits $1.5M To CDC Foundation For Education Program

May 29, 2009

Prevention Trial Could Stand On Its Own

October 28, 1994

Under Ultimatum, NIH Databases Remove “Misconduct” Tags From Papers By Fisher

February 24, 1995

Nutrition Program Announcement Lists Suggested Areas For Research

September 22, 1978